EHD2 and malignant glioma: On the contrary, EHD2 overexpression was found as a component of a mesenchymal signature in malignant gliomas with shorter survival, and knockdown analyses showed the EHD2 requirement for cell proliferation, migration, and invasion (Zhang et al., 2021).